CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Bactek-RWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.08

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Prospective, Open-label, Randomized Pilot Study With BACTEK-R (MV130) as Control Group, Administered Sublingually to Assess the Clinical Impact in Subject With Mild Pneumonia Due to COVID-19 Infection

The purpose of the study is to confirm if BACTEK-R (MV130) provides clinical benefit in subject with mild pneumonia (CURB-65≤2) by COVID-19 admitted to the Hospital.

NCT04363814 COVID-19 Biological: Bactek-R
MeSH:Pneumonia
HPO:Pneumonia

Primary Outcomes

Description: Number of subjects presenting a improvement in their clinical condition from day 1 to 14 that lead their hospital discharged. Based on the measure of the secondary outcomes.

Measure: Clinical recovery

Time: 2 weeks

Description: Number of subjects presenting a worsening in their clinical condition from day 1 to 14 that leads to their admission to the intensive care unit or their death. Based on the measure of the secondary outcomes.

Measure: Clinical worsening

Time: 2 weeks

Secondary Outcomes

Description: Symptom (fever, cough, dyspnea, myalgia, diarrhea and so on) will be daily record and classified as mild, moderate, severe.

Measure: Clinical severity

Time: 2 weeks

Description: Time of reduction or disappearance of the symptoms

Measure: Time to symptoms remission

Time: 2 weeks

Description: Record of all the medication administered to the subject

Measure: Medication Use

Time: 2 weeks

Description: Time from the subject's admission to the coronavirus unit until discharge

Measure: Hospitalization time

Time: 2 weeks

Description: Blood routine test will be carried out days 1 and 7

Measure: Blood routine test

Time: Days 1 and 7

Description: Heart rate will be followed everyday during time frame

Measure: Heart rate

Time: 2 weeks

Description: Blood pressure will be followed everyday during time frame

Measure: Blood pressure

Time: 2 weeks

Description: Cardiac auscultation will be recorded everyday during time frame

Measure: Cardiac auscultation

Time: 2 weeks

Description: Blood oxygen saturation will be followed everyday during time frame

Measure: Oxygen saturation

Time: 2 weeks

Description: Adverse events during treatment

Measure: Adverse events

Time: 2 weeks


Related HPO nodes (Using clinical trials)